Search research articles
Contact Us
Filters
Showing results (111-120 of 330) with videos related to
Page
of 33
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 29, 2022
The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer
Yee-Ming M Cheung, Melissa Hughes, Julia Harrod, et al.
World Neurosurgery
|
April 30, 2019
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases
Alexander F C Hulsbergen, Nayan Lamba, An Claes, et al.
The Oncologist
|
August 5, 2018
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria
Kelsey H Natsuhara, Katya Losk, Tari A King, et al.
Breast Cancer Research and Treatment
|
September 13, 2012
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D Arvold, Kevin S Oh, Andrzej Niemierko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 1, 2024
Concordance of PD-L1 Expression in Metastatic Triple-negative Breast Cancer Between the 22C3 and E1L3N Antibodies Using Combined Positive Scoring
Timothy K Erick, Susan C Lester, Ana C Garrido-Castro, et al.
Journal of the National Cancer Institute
|
December 30, 2022
Survival in male breast cancer over the past 3 decades
José P Leone, Rachel A Freedman, Julieta Leone, et al.
Journal of Oncology Practice
|
September 1, 2017
Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation
Katya Losk, Rachel A Freedman, Nancy U Lin, et al.
Breast Cancer Research and Treatment
|
September 17, 2020
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center
Katya Losk, Rachel A Freedman, Alison Laws, et al.
JAMA Oncology
|
February 29, 2024
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer
Julieta Leone, Michael J Hassett, Rachel A Freedman, et al.
Neuro-Oncology
|
November 11, 2022
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries
Nayan Lamba, Daniel N Cagney, Paul J Catalano, et al.
Page
of 33
Search research articles
Search
Showing results (111-120 of 330) with videos related to
Sort By:
Page
of 33
The Journal of Clinical Endocrinology and Metabolism
|
June 29, 2022
The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer
Yee-Ming M Cheung, Melissa Hughes, Julia Harrod, et al.
World Neurosurgery
|
April 30, 2019
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases
Alexander F C Hulsbergen, Nayan Lamba, An Claes, et al.
The Oncologist
|
August 5, 2018
Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria
Kelsey H Natsuhara, Katya Losk, Tari A King, et al.
Breast Cancer Research and Treatment
|
September 13, 2012
Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype
Nils D Arvold, Kevin S Oh, Andrzej Niemierko, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
October 1, 2024
Concordance of PD-L1 Expression in Metastatic Triple-negative Breast Cancer Between the 22C3 and E1L3N Antibodies Using Combined Positive Scoring
Timothy K Erick, Susan C Lester, Ana C Garrido-Castro, et al.
Journal of the National Cancer Institute
|
December 30, 2022
Survival in male breast cancer over the past 3 decades
José P Leone, Rachel A Freedman, Julieta Leone, et al.
Journal of Oncology Practice
|
September 1, 2017
Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation
Katya Losk, Rachel A Freedman, Nancy U Lin, et al.
Breast Cancer Research and Treatment
|
September 17, 2020
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center
Katya Losk, Rachel A Freedman, Alison Laws, et al.
JAMA Oncology
|
February 29, 2024
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer
Julieta Leone, Michael J Hassett, Rachel A Freedman, et al.
Neuro-Oncology
|
November 11, 2022
Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries
Nayan Lamba, Daniel N Cagney, Paul J Catalano, et al.
Page
of 33